Magang, Jesarine C.
HRN: 26-54-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/20/2025
01/26/2025
IV
1550 Mg
Q6H
Acute Glomerulonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes